These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37356137)

  • 41. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol.
    Budhian A; Siegel SJ; Winey KI
    J Microencapsul; 2005 Nov; 22(7):773-85. PubMed ID: 16421087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Engineering the lipid layer of lipid-PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stability.
    Hu Y; Hoerle R; Ehrich M; Zhang C
    Acta Biomater; 2015 Dec; 28():149-159. PubMed ID: 26428192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
    Zhao K; Zhang Y; Zhang X; Shi C; Wang X; Wang X; Jin Z; Cui S
    Int J Nanomedicine; 2014; 9():4609-19. PubMed ID: 25356070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.
    Tan Z; Liu W; Liu H; Li C; Zhang Y; Meng X; Tang T; Xi T; Xing Y
    Eur J Pharm Biopharm; 2017 Feb; 111():33-43. PubMed ID: 27865932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.
    Wang C; Muttil P; Lu D; Beltran-Torres AA; Garcia-Contreras L; Hickey AJ
    AAPS J; 2009 Mar; 11(1):139-47. PubMed ID: 19277872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
    Voon SH; Tiew SX; Kue CS; Lee HB; Kiew LV; Misran M; Kamkaew A; Burgess K; Chung LY
    J Biomed Nanotechnol; 2016 Jul; 12(7):1431-52. PubMed ID: 29336539
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2.
    Ucar B; Acar T; Arayici PP; Derman S
    Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34375967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus.
    Marasini N; Khalil ZG; Giddam AK; Ghaffar KA; Hussein WM; Capon RJ; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Int J Pharm; 2016 Nov; 513(1-2):410-420. PubMed ID: 27659862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.
    Wang G; Pan L; Zhang Y; Wang Y; Zhang Z; Lü J; Zhou P; Fang Y; Jiang S
    PLoS One; 2011; 6(11):e27605. PubMed ID: 22110686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cationic Nanoparticle-Stabilized Vaccine Delivery System for the H9N2 Vaccine to Promote Immune Response in Chickens.
    Zhang Y; Zhu T; Xu S; Gu P; Cai G; Peng S; Liu Z; Yang Y; Hu Y; Liu J; Wang D
    Mol Pharm; 2023 Mar; 20(3):1613-1623. PubMed ID: 36795759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Encapsulation of Poly I:C and the natural phosphodiester CpG ODN enhanced the efficacy of a hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticle vaccine in TC-1-grafted tumors.
    Liu C; Chu X; Yan M; Qi J; Liu H; Gao F; Gao R; Ma G; Ma Y
    Int J Pharm; 2018 Dec; 553(1-2):327-337. PubMed ID: 30393151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new poly(I:C)-decorated PLGA-PEG nanoparticle promotes Mycobacterium tuberculosis fusion protein to induce comprehensive immune responses in mice intranasally.
    Du X; Tan D; Gong Y; Zhang Y; Han J; Lv W; Xie T; He P; Hou Z; Xu K; Tan J; Zhu B
    Microb Pathog; 2022 Jan; 162():105335. PubMed ID: 34861347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity.
    Keijzer C; Slütter B; van der Zee R; Jiskoot W; van Eden W; Broere F
    PLoS One; 2011; 6(11):e26684. PubMed ID: 22073184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
    Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
    Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying.
    Fonte P; Soares S; Costa A; Andrade JC; Seabra V; Reis S; Sarmento B
    Biomatter; 2012; 2(4):329-39. PubMed ID: 23507897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases.
    Pirooznia N; Hasannia S; Lotfi AS; Ghanei M
    J Nanobiotechnology; 2012 May; 10():20. PubMed ID: 22607686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.
    Fairley SJ; Singh SR; Yilma AN; Waffo AB; Subbarayan P; Dixit S; Taha MA; Cambridge CD; Dennis VA
    Int J Nanomedicine; 2013; 8():2085-99. PubMed ID: 23785233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy.
    Ma W; Smith T; Bogin V; Zhang Y; Ozkan C; Ozkan M; Hayden M; Schroter S; Carrier E; Messmer D; Kumar V; Minev B
    J Transl Med; 2011 Mar; 9():34. PubMed ID: 21450109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
    Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
    J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.